Jon I Williams

发表

A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.

A. Tolcher, C. Takimoto, A. Patnaik, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression

Jon I Williams, Dan Li, Richard J Pietras, 2002, Oncogene.

Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.

M. Abelson, Jon I Williams, P. Gomes, 2010, American journal of ophthalmology.

Human Diseases Associated with Defective DNA Repair

E. Friedberg, U. Ehmann, Jon I Williams, 1979 .

Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.

Jon I Williams, J. Vittitow, 2018, Journal of cataract and refractive surgery.

Efficacy of a One-Piece Aberration Neutral Hydrophobic Acrylic Toric Intraocular Lens

M. Packer, Jon I Williams, P. Buckhurst, 2022, Clinical ophthalmology.

OPTH_A_386551 3763..3774

M. Packer, Jon I Williams, P. Buckhurst, 2022 .

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.

M. Abelson, Jon I Williams, G. Torkildsen, 2009, Clinical therapeutics.

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%

Jon I Williams, P. Gomes, Jon I. Williams, 2014, Clinical ophthalmology.

FIRST-IN-HUMAN CLINICAL STUDY TO INVESTIGATE THE EFFECTIVENESS AND SAFETY OF PARS PLANA VITRECTOMY SURGERY USING A NEW HYPERSONIC TECHNOLOGY

A. Agarwal, P. Stanga, D. Kumar, 2018, Retina.

Solid phase synthesis of bioadhesive analogue peptides with trifluoromethanesulfonic acid cleavage from PAM resin

R. Sedgwick, Jon I Williams, M. Swerdloff, 2009 .

REPAIR OF UV IRRADIATION DAMAGE IN SIMIAN VIRUS 40

J. Cleaver, Jon I Williams, 1978 .

CELL SURVIVAL, EXCISION REPAIR AND DNA REPLICATION IN EUKARYOTIC CELLS

L. Kapp, J. Cleaver, Jon I Williams, 1978 .

Apparent receptor-mediated activation of Ca2+-dependent conductive Cl- transport by shark-derived polyaminosterols.

D. Vandorpe, Lianwei Jiang, S. Alper, 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge.

M. Abelson, Jon I Williams, G. Torkildsen, 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate

A. Salapatek, Jon I Williams, Jon I. Williams, 2010, Current medical research and opinion.

A Phase I and Pharmacokinetic Study of Squalamine , an Aminosterol Angiogenesis Inhibitor 1

A. Tolcher, C. Takimoto, A. Patnaik, 2003 .

A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

R. Herbst, D. Carbone, S. Solomon, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.

Kathryn S. Kennedy, M. Abelson, Jon I Williams, 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Squalamine Lactate Reduces Choroidal Neovascularization in a Laser-Injury Model in the Rat

R. Danis, K. Holroyd, T. Ciulla, 2003, Retina.

EFFECT OF SQUALAMINE ON IRIS NEOVASCULARIZATION IN MONKEYS

K. Holroyd, G. Peyman, D. Blake, 2002, Retina.

Prospective multicenter clinical trial to evaluate the safety and effectiveness of a new glistening-free one-piece acrylic toric intraocular lens

M. Packer, Jon I Williams, G. Feinerman, 2018, Clinical ophthalmology.

Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies.

D. V. Von Hoff, M. Zasloff, K. Holroyd, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.

John D. Davis, T. L. Chao, J. Laterra, 1998, Cancer research.

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%

Jon I Williams, P. Gomes, M. Bergmann, 2014, Clinical ophthalmology.

Regression of Retinopathy by Squalamine in a Mouse Model

R. Higgins, M. Zasloff, Jon I Williams, 2004, Pediatric Research.

Efficacy of bepotastine besilate ophthalmic solution 1.5% for seasonal allergic conjunctivitis: a randomized, placebo-controlled, natural exposure, clinical trial.

W. Carr, P. Ratner, Jon I Williams, 2013, Allergy and asthma proceedings.

Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis

W. Carr, M. Cavet, Jon I Williams, 2018, Journal of asthma and allergy.

Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.

J. Peace, Jon I Williams, B. Silverstein, 2018, Journal of cataract and refractive surgery.

Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.

Jon I Williams, J. Vittitow, 2020, Journal of cataract and refractive surgery.